| Genetic and epigenetic events generate multiple pathways in colorectal cancer progression M Pancione, A Remo, V Colantuoni Pathology research international 2012, 2012 | 200 | 2012 |
| Leptin/HER2 crosstalk in breast cancer: In vitro study and preliminary in vivoanalysis E Fiorio, A Mercanti, M Terrasi, R Micciolo, A Remo, A Auriemma, ... BMC cancer 8 (1), 1-11, 2008 | 119 | 2008 |
| Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification: Evaluation According to ASCO/CAP Criteria M Brunelli, E Manfrin, G Martignoni, K Miller, A Remo, D Reghellin, ... American journal of clinical pathology 131 (5), 678-682, 2009 | 115 | 2009 |
| Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis M Pancione, G Giordano, A Remo, A Febbraro, L Sabatino, E Manfrin, ... Journal of immunology research 2014, 2014 | 85 | 2014 |
| HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy M Brunelli, E Manfrin, G Martignoni, S Bersani, A Remo, D Reghellin, ... American journal of clinical pathology 129 (6), 907-911, 2008 | 72 | 2008 |
| Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1 RS Arnold, J He, A Remo, D Ritsick, Q Yin-Goen, JD Lambeth, MW Datta, ... The American journal of pathology 171 (6), 2021-2032, 2007 | 65 | 2007 |
| Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept G Giordano, A Febbraro, M Venditti, S Campidoglio, N Olivieri, K Raieta, ... Gastroenterology research and practice 2014, 2014 | 58 | 2014 |
| Role of molecular markers in diagnosis and prognosis of renal cell carcinoma. G Martignoni, M Brunelli, S Gobbo, A Remo, V Ficarra, P Cossu-Rocca, ... Analytical and quantitative cytology and histology 29 (1), 41-49, 2007 | 57 | 2007 |
| Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases E Manfrin, A Remo, F Falsirollo, D Reghellin, F Bonetti Breast cancer research and treatment 107 (3), 371-377, 2008 | 54 | 2008 |
| Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer G Giordano, A Febbraro, E Tomaselli, ML Sarnicola, P Parcesepe, ... Journal of experimental & clinical cancer research 34 (1), 1-11, 2015 | 49 | 2015 |
| ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor R Zanotti, A Ambrosetti, M Lestani, P Ghia, C Pattaro, A Remo, F Zanetti, ... Leukemia 21 (1), 102-109, 2007 | 49 | 2007 |
| Expression of aromatase and estrogen receptors in human adrenocortical tumors L Barzon, G Masi, M Pacenti, M Trevisan, F Fallo, A Remo, G Martignoni, ... Virchows Archiv 452 (2), 181-191, 2008 | 47 | 2008 |
| Immunohistochemical evaluation of mismatch repair proteins in colorectal carcinoma: the AIFEG/GIPAD proposal. A Remo, M Fassan, G Lanza Pathologica 108 (3), 104-109, 2016 | 46 | 2016 |
| Ensemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPARγ and TNFα signaling SM Pagnotta, C Laudanna, M Pancione, L Sabatino, C Votino, A Remo, ... PloS one 8 (8), e72638, 2013 | 44 | 2013 |
| Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer A Remo, I Simeone, M Pancione, P Parcesepe, P Finetti, L Cerulo, ... Journal of translational medicine 13 (1), 1-13, 2015 | 42 | 2015 |
| Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions SF Crinò, L Bernardoni, L Brozzi, L Barresi, G Malleo, R Salvia, L Frulloni, ... Gastrointestinal Endoscopy 90 (6), 933-943, 2019 | 36 | 2019 |
| Benign breast lesions at risk of developing cancer—A challenging problem in breast cancer screening programs: Five years' experience of the Breast Cancer Screening Program in … E Manfrin, R Mariotto, A Remo, D Reghellin, F Falsirollo, D Dalfior, ... Cancer 115 (3), 499-507, 2009 | 34 | 2009 |
| Cancer size, histotype, and cellular grade may limit the success of fine‐needle aspiration cytology for screen‐detected breast carcinoma E Manfrin, F Falsirollo, A Remo, D Reghellin, R Mariotto, D Dalfior, ... Cancer Cytopathology: A Journal of the American Cancer Society 117 (6), 491-499, 2009 | 33 | 2009 |
| Morphology and molecular features of rare colorectal carcinoma histotypes A Remo, M Fassan, A Vanoli, LR Bonetti, V Barresi, F Tatangelo, R Gafà, ... Cancers 11 (7), 1036, 2019 | 31 | 2019 |
| t (6; 11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid … A Caliò, M Brunelli, D Segala, S Pedron, R Tardanico, A Remo, S Gobbo, ... Modern Pathology 31 (3), 474-487, 2018 | 31 | 2018 |
guido martignoniUniversity of VeronaVerified email at univr.it
